Brief: Virbac Acquires Thyronorm
Dec 16 (Reuters) - Virbac SA VIRB.PA: ACQUIRES THYRONORM DEAL VALUED AT £100 MILLION, ACCRETIVE TO SALES GROWTH FROM YEAR 1 NORBROOK TO CONTINUE AS PRODUCT'S MANUFACTURER ACQUISITION EXPECTED TO BE ACCRETIVE TO VIRBAC GROUP SALES GROWTH AND EBITDA MARGIN FROM YEAR 1 Source text: ID:nGNE3pvGl5 Further company coverage: VIRB.PA (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Virbac SA
See all newsFrance's Virbac Q3 revenue rises on strength in Both Companion Animal, Farm Animal segments
Brief: Virbac Sees 2026 Targets At Upper End Of Range
Bernstein lifts Virbac to 'outperform', as Supercharge portfolio boosts margins
French and Benelux stocks-Factors to watch on September 18
Virbac confirms outlook as Supercharge platforms drive profit growth